# Botulinum Toxin type A

## Botox 100 Unit/Vial

| TAH Drug Code      | [IBOT](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IBOT)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | 1. Strabismus and blepharospasm caused by insufficient muscle tone in patients over 12 years old, including benign primary blepharospasm or seventh cranial nerve disorder, and hemifacial spasm. Note: "Strabismus" is for use by ophthalmologists only. 2. Reduces subjective symptoms and objective symptoms of spastic torticollis (cervical dystonia). 3. local spasm Upper limb spasticity in adults. Lower extremity spasticity in adult patients to reduce the severity of increased muscle tone in the ankle and toe flexor muscles (gastrocnemius, soleus, tibialis posterior, flexor pollicis longus, and flexor digitorum longus). Patients over 2 years old have muscle spasms in the lower limbs caused by juvenile cerebral palsy, including dynamic clubfoot deformity. 4. Primary axillary hyperhidrosis. 5. bladder dysfunction Adult patients with urinary incontinence due to detrusor hyperactivity caused by spinal cord lesions and who are ineffective or intolerant to choline drug treatment. Adult patients with overactive bladder, such as urinary incontinence, urinary urgency and frequent urination, who have poor response to anticholinergic drugs or cannot tolerate them and must stop taking them, and who are willing and able to take a clean break after treatment if necessary. Clean intermittent catheterization. Note: The results of the Phase III pivotal trial for this indication did not directly show that the efficacy of this drug is superior to anticholinergic drugs, nor did they explore the efficacy and safety of the combined use of this drug and anticholinergic drugs. 6. Temporarily improves the appearance of dynamic wrinkles on the upper face of adults caused by frown lines, crow's feet, and forehead wrinkles. 7. Protruding lower facial muscles Improves the appearance of masseter prominence in adults. Improving the appearance of prominent sternocleidomastoid muscle in adults. 8. Preventive treatment of headaches in adult patients with chronic migraine (at least 3 months, ?15 days per month, lasting more than 4 hours each time, and at least half of the headaches are migraines).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | Strabismus: Intramuscular. Vertical muscles and for horizontal strabismus of < 20 prism diopters: 1.25-2.5 units in any one muscle. Horizontal strabismus of 20-50 prism diopters: 2.5-5 units in any one muscle. Persistent VI nerve palsy of >= 1 month: 1.25-2.5 units in the medial rectus muscle. Maximum: 25 units as single injection for any one muscle. Blepharospasm: Intramuscular. Initially 1.25-2.5 units injected into the medial and lateral pretarsal orbicularis oculi of the upper lid and into the lateral pretarsal orbicularis oculi of the lower lid. Maximum cumulative dose: 200 units in 2-month period. VII nerve disorders: Patients with hemifacial spasm or VII nerve disorder should be treated as for unilateral blepharospasm. Maximum cumulative dose: 200 units in 2-month period. Spastic torticollis (Cervical dystonia): Intramuscular. Individualised dosing. Maximum cumulative dose:<= 360 units in 2-month period and administer no more frequently than every 2 months. Spasticity (due to juvenile cerebral palsy) in patients 2 years of age and older: Intramuscular. 4 units/kg into each of 2 sites in the medial and lateral heads of the gastrocnemius muscle of the affected lower limb(s). Maximum total dose in 30-day period: 200 units. Primary axillary hyperhidrosis: 50 unit intradermally to each axilla evenly distributed in multiple sites about 1-2 cm apart. Administer no more frequently than every 2 months. Reduction of glabellar lines: Intramuscular. Inject 4 units into each of 5 sites, two in each corrugator muscle and one in the procerus muscle for a total dose of 20 units. Reduction of lateral canthus lines (Crow's feet): Intramuscular. Inject 2-6 units into 3 injection sites per side (6 total injection points) in the lateral orbicularis oculi muscle. Reduction of forehead lines: Intramuscular. Inject 2 to 6 units into each of four sites in the frontalis muscle every 1 to 2 cm along either side of forehead crease and 2 to 3 cm above eyebrows for total dose of 8-24 units. Stroke-related upper limb spasticity: Intramuscular. Inject into selected muscles (typically the flexor muscles of the elbow, wrist & fingers), start with lowest dose, maximum: 50 units/site. Maximum dose per treatment session: 360 units. May be repeated when the effects have lessened, but generally no sooner than 12 weeks after the previous injection. Lower limb spasticity: Intramuscular. Total dose of 300 to 400 units IM divided among 5 muscles (gastrocnemius, soleus, posterior tibial, flexor pollicis longus and flexor digitorum longus). May be repeated when the effects have lessened, but generally no sooner than 12 weeks after the previous injection. Chronic migraine: Intramuscular. Total dose of 155 units as 5 units into each of 31 sites divided across 7 specific head/neck muscle areas. Usual retreatment every 12 weeks. Bladder dysfunction: Intradetrusor. Detrusor overactivity associated with neurologic condition: Total dose of 100 units/treatment initially, may increase to the maximum: 200 units/treatment, if necessary. Overactive bladder: Total dose of 100 units administered as twenty 10 units injections into the detrusor muscle; injections should be spaced approximately 1 cm apart. Median time to retreatment is approximately 24 weeks, but should be no sooner than 12 weeks. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Contraindications  | Hypersensitivity to any component of the formulation. Myasthenia gravis or Eaton Lambert syndrome. Infection at the injection site. patients with urinary tract infection, acute urinary retention and post-voiding residual urine volume exceeding 200 mL without regular clean intermittent catheterization (CIC).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Adverse Effects    | Localized pain, tenderness &/or bruising, local weakness, ptosis, vertical deviation, irritation/tearing. Rarely, skin rash (including erythema multiforme, urticaria & psoriasiform eruption), pruritus, allergic reactions, dysphagia, pneumonia. Dermatologic: Injection site reaction (cervical dystonia, 5% to 22%; glabellar lines, 3% ) Gastrointestinal: Xerostomia (cervical dystonia, 13% to 39% ) Musculoskeletal: Muscle weakness (cervical dystonia, 11% to 56% ) Neurologic: Difficulty speaking (cervical dystonia, 6% to 28% ), Headache (9% to 11% ) Ophthalmic: Disorder of eye (cervical dystonia, 6% to 17% ) Respiratory: Nasopharyngitis (glabellar lines, 10% )                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| More Info          | [UpToDate](https://www.uptodate.com/contents/onabotulinumtoxina-botox-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

